Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Semisynthetic pneumocandin analogue for fungal infections

Oct. 4, 1996

PathoGenesis selects nitroimidazopyran as potential tuberculosis Rx

Oct. 4, 1996

IntraBiotics' protegrins as potential treatments for multi-drug-resistant infections & gastric ulcer

Oct. 4, 1996

Potential antitubercular agents from PathoGenesis

Oct. 4, 1996

Another series of multifunctional antibacterial agents from P&G

Oct. 4, 1996

Quinolonyl-carbapenems from P&G

Oct. 4, 1996

Orally active ester-type carbapenem prodrug from Sankyo

Oct. 4, 1996

Novel carbapenem with anti-MRSA activity from Banyu

Oct. 4, 1996

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...